The patients that exhibited high expression of the CA-B markers exhibited lower overall survival (Fig. 8n), implying that the CA-B chromatin accessibility profile was associated with a poor outcome in ER + /HER2 − tumours. The gene discussed is ESR1; the disease is neoplasm.